Asset Allocation

As of October 31, 2025.
Type % Net
Cash 2.73%
Stock 59.07%
Bond 32.15%
Convertible 0.00%
Preferred 4.74%
Other 1.32%
View Asset Allocation
Start Trial

Market Capitalization

As of October 31, 2025
Large 81.26%
Mid 15.66%
Small 3.08%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.30%    % Emerging Markets: 0.20%    % Unidentified Markets: 0.49%

Americas 98.90%
97.55%
Canada 91.01%
United States 6.54%
1.35%
Chile 0.03%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.54%
United Kingdom 0.43%
0.11%
France 0.02%
Germany 0.05%
Greece 0.00%
Ireland 0.00%
Italy 0.00%
Netherlands 0.03%
Spain 0.00%
0.00%
0.00%
Greater Asia 0.06%
Japan 0.03%
0.00%
Australia 0.00%
0.04%
Singapore 0.04%
0.00%
Unidentified Region 0.49%

Bond Credit Quality Exposure

AAA 19.86%
AA 13.25%
A 16.16%
BBB 22.66%
BB 11.83%
B 5.43%
Below B 0.31%
    CCC 0.31%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.05%
Not Available 10.46%
Short Term 0.00%
As of October 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
41.39%
Materials
1.24%
Consumer Discretionary
3.52%
Financials
33.38%
Real Estate
3.25%
Sensitive
35.09%
Communication Services
1.70%
Energy
15.89%
Industrials
14.88%
Information Technology
2.62%
Defensive
9.23%
Consumer Staples
4.74%
Health Care
0.00%
Utilities
4.49%
Not Classified
14.29%
Non Classified Equity
1.69%
Not Classified - Non Equity
12.60%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government 20.22%
Corporate 51.67%
Securitized 0.01%
Municipal 21.52%
Other 6.58%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
6.66%
Less than 1 Year
6.66%
Intermediate
57.84%
1 to 3 Years
11.73%
3 to 5 Years
20.65%
5 to 10 Years
25.46%
Long Term
33.12%
10 to 20 Years
7.50%
20 to 30 Years
11.92%
Over 30 Years
13.70%
Other
2.38%
As of October 31, 2025
View Bond Maturity Exposure
Start Trial